In Pictures - Spotlight shines on Vivek Ramaswamy as he takes center stage in the 2024 Republican presidential debate
时间:2024-09-27 22:44:51 阅读(143)
The third Republican debate went live in Miami, and the candidate for the 2024 United States (US) presidential polls was looking toward the 2024 Republican presidential candidate. Among these Republican candidates, one is Vivek Ramaswamy, who took the stage in Miami for the third GOP primary debate. He was joined by former President Donald Trump, Florida Gov. Ron DeSantis, former UN Ambassador Nikki Haley, and former Vice President Mike Pence. Here is more about ramaswamy career, and his life. (AP Photo)2/9
Vivek Ramaswamy is an American entrepreneur and author, who is running for the 2024 Republican Party presidential nomination. He is the founder of Roivant Sciences, a pharmaceutical company, and Strive Asset Management, an investment firm. He is also the author of the book Woke, Inc.(AP Photo)
3/9Ramaswamy was born on August 9, 1985, in Cincinnati, Ohio, to Indian Hindu immigrant parents from Kerala. He grew up in a conservative and religious household, attending a local Hindu temple and a Catholic school.(AP Photo)
4/9Ramaswamy graduated from Harvard College in 2007 with a bachelor’s degree in biology, summa cum laude. He was a member of the Phi Beta Kappa honor society and the president of the Harvard Political Union. He then attended Yale Law School, where he earned his J.D. degree in 2010. He was a Paul and Daisy Soros Fellow and a recipient of the Potter Stewart Prize for the best moot court brief.(AP Photo)
5/9Ramaswamy started his career as an investment banker at Goldman Sachs in 2008, where he worked on mergers and acquisitions in the healthcare sector. He then joined QVT Financial, a hedge fund, as an investment partner in 2012. He specialized in biotechnology and pharmaceutical investments, and developed a strategy of acquiring the rights to promising drugs from large companies and developing them through smaller subsidiaries.(AP Photo)
6/9Ramaswamy founded Roivant Sciences in 2014, with the vision of creating a new kind of pharmaceutical company that would focus on developing drugs for unmet medical needs. He raised over $3 billion in funding from investors such as SoftBank, Novartis, and the Qatar Investment Authority. He also launched several spin-off companies under the Roivant umbrella, such as Axovant (neurology), Myovant (women’s health), and Urovant (urology).(AP Photo)
7/9Ramaswamy stepped down as the CEO of Roivant in 2020, and became the executive chairman of the company. He also co-founded Strive Asset Management, an investment firm that focuses on biotechnology and healthcare. He remains the largest shareholder of Roivant, which went public in 2021 through a merger with a special purpose acquisition company (SPAC). As of 2023, Forbes estimated Ramaswamy’s net worth at more than $950 million.(AP Photo)
8/9Ramaswamy announced his candidacy for the 2024 Republican Party presidential nomination in February 2023, becoming the first Indian-American to run for the highest office in the United States. He is running on a platform of defending the American identity and values from what he calls the “new secular religions” of COVID-ism, climate-ism, and gender ideology. He is also a vocal opponent of environmental, social, and corporate governance (ESG) initiatives, which he views as a threat to free enterprise and democracy.(AP Photo)
9/9Ramaswamy is married to Apoorva Tewari, a physician and a graduate of Harvard Medical School. They have two sons, Karthik and Arjun, and live in Butler County, Ohio. Ramaswamy identifies as a monotheistic Hindu, and follows a vegetarian diet. He is fluent in Tamil and can understand Malayalam. He is also a fan of Eminem and has performed rap songs under the stage name Da Vek.(AP Photo)
猜你喜欢
- Sensex tops 60200 on weekly F&O expiry, Nifty support at 17850, ‘remain cautious while adding long positions’
- February fuel demand hits highest level in 24 years on back of cheap Russian oil
- Fifth column by Tavleen Singh- Please answer the questions
- Sebi returns OYO’s draft IPO papers; asks to refile with updates
- Nifty, Sensex end at record highs amid dovish Fed, positive PMI; could see consolidation at higher levels
- Fed’s SVB balm fails to calm markets
- Nifty to reclaim 20,100 or fall in trade- See GIFT Nifty, FII data, crude, F&O ban, more before market opens
- Nifty to top 17000 or extend losses- Check 7 things to know before market opens
- Nifty to show trend reversal or sink further in trade- See GIFT Nifty, FII data, F&O ban, crude, more before market opens